Argenx Se (ARGX) Prepaid Assets (2015 - 2026)

Argenx Se (ARGX) posted quarterly Prepaid Assets of $572.0 million for Q2 2026, down 99.84% year-on-year from $362.7 billion in Q2 2025, and up 74.39% on a QoQ basis from $328.0 million in Q4 2025.

Argenx Se (ARGX) Prepaid Assets (2015 - 2026) Analysis & Trends

Argenx Se (ARGX) has reported Prepaid Assets for 12 consecutive years, with $572.0 million the latest figure, recorded in Q2 2026.

  • Quarterly Prepaid Assets fell 99.84% year-over-year to $572.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $572.0 million (down 99.84% YoY) and the FY2025 annual result came in at $328.0 million, up 74.52% from the prior year.
  • Prepaid Assets climbed to $572.0 million in Q2 2026 per ARGX's latest filing, from $328.0 million in the prior quarter.
  • Over the last five years, Prepaid Assets for ARGX reached as high as $362.7 billion in Q2 2025 and fell as low as $76.0 million in Q4 2022.
  • A 5-year average of $40.5 billion and a median of $179.4 million in 2024 frame the typical range for Prepaid Assets.
  • Annual changes were most pronounced in 2025 — Prepaid Assets jumped 202059.74% — and 2026, when it slumped 99.84%.
  • Year by year, Prepaid Assets stood at $76.0 million in 2022, then jumped by 76.36% to $134.1 million in 2023, then jumped by 40.18% to $187.9 million in 2024, then jumped by 74.52% to $328.0 million in 2025, then soared by 74.39% to $572.0 million in 2026.
  • According to Business Quant data, Prepaid Assets over the past three periods registered $572.0 million, $328.0 million, and $362.7 billion for Q2 2026, Q4 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Alnylam Pharmaceuticals 35.71 Bn 32.70 Bn 959.66 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 572.00 Mn
Dec 31, 2025 328.00 Mn
Jun 30, 2025 362.72 Bn
Dec 31, 2024 187.95 Mn
Jun 30, 2024 179.42 Mn
Dec 31, 2023 134.07 Mn
Jun 30, 2023 138.83 Mn
Dec 31, 2022 76.02 Mn
Jun 30, 2022 82.31 Mn
Dec 31, 2021 58.95 Mn
Jun 30, 2021 62.40 Mn
Dec 31, 2020 25.89 Mn
Jun 30, 2020 12.36 Mn
Dec 31, 2019 10.27 Mn
Jun 30, 2019 9.47 Mn
Dec 31, 2018 3.41 Mn
Jun 30, 2018 6.81 Mn
Dec 31, 2017 3.37 Mn
Jun 30, 2017 3.41 Mn
Dec 31, 2016 3.10 Mn